Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40
Nature Medicine1999Vol. 5(7), pp. 780–787
Citations Over TimeTop 10% of 1999 papers
Eduardo M. Sotomayor, Ivan Borrello, Erev E. Tubb, Frédérique‐Marie Rattis, Harold Bien, Zhengbin Lu, Steve Fein, Stephen P. Schoenberger, Hyam I. Levitsky
Related Papers
- → CD40, but Not CD154, Expression on B Cells Is Necessary for Optimal Primary B Cell Responses(2003)81 cited
- → Cross‐priming of CD8+ T cells by viral and tumor antigens is a robust phenomenon(2003)83 cited
- → Normal CD40-mediated activation of monocytes and dendritic cells from patients with hyper-IgM syndrome due to a CD40 pathway defect in B cells(1998)24 cited
- → PRIMING POTENCY OF THE PRODUCTS OF INDIVIDUAL REGIONS OF THE H‐2 COMPLEX AND THEIR ROLE IN THE RESTIMULATION IN SECONDARY MLC(1978)2 cited
- → Normal CD40-mediated activation of monocytes and dendritic cells from patients with hyper-IgM syndrome due to a CD40 pathway defect in B cells(1998)2 cited